nicorandil has been researched along with Dyspnea in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, HT; Lin, CC; Tarng, DC; Wu, YT; Yang, WC | 1 |
| Fujinaga, H; Fujisawa, K; Harada, K; Harada, T; Iima, T; Kageyama, N; Kawata, A; Okada, A; Okumura, T; Saito, A; Shigekiyo, M; Terada, N; Yamamoto, H; Yamamoto, T | 1 |
1 trial(s) available for nicorandil and Dyspnea
| Article | Year |
|---|---|
Intravenous nicorandil for treatment of the urgent phase acute heart failure syndromes: A randomized, controlled trial.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Diastole; Dyspnea; Echocardiography; Emergency Service, Hospital; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Japan; Male; Middle Aged; Nicorandil; Nitroglycerin; Outcome Assessment, Health Care; Prospective Studies; Treatment Outcome; Vasodilator Agents; Ventricular Function, Left | 2017 |
1 other study(ies) available for nicorandil and Dyspnea
| Article | Year |
|---|---|
Nicorandil-Induced Hyperkalemia in a Hemodialysis Patient.
Topics: Adenosine Triphosphate; Aged, 80 and over; Dizziness; Dyspnea; Female; Humans; Hyperkalemia; Kidney Failure, Chronic; Nicorandil; Potassium Channels; Renal Dialysis; Vasodilator Agents | 2017 |